Home / Angiogenin / Recombinant Human Angiogenin Protein

Recombinant Human Angiogenin Protein

Catalog #: 265-AN
10 Citations Datasheet

Carrier Free

Catalog # Availability Size / Price Qty
265-AN-050/CF
265-AN-250/CF

With Carrier

Catalog # Availability Size / Price Qty
265-AN-050
265-AN-250
R&D Systems Recombinant Proteins and Enzymes
1 Image
Product Details
Citations (10)
FAQs
Reviews
Summary Product Datasheets Carrier Free Data Images Reconstitution Calculator Background Related Research Areas

Recombinant Human Angiogenin Protein Summary

Product Specifications

Purity
>97%, by SDS-PAGE under reducing conditions and visualized by silver stain
Endotoxin Level
<1.0 EU per 1 μg of the protein by the LAL method.
Activity
Measured by its ribonucleolytic activity toward yeast tRNA. Lee and Vallee (1989) Biochem. Biophys. Res. Commun. 161:121. Angiogenin produces a delta Abs260/μg >1.0 in two hours, as measured under the described conditions.
Source
E. coli-derived human Angiogenin protein
Gln25-Pro147
Accession #
Q53X86
N-terminal Sequence
Analysis
Gln25
Predicted Molecular Mass
14 kDa
SDS-PAGE
14 kDa, reducing conditions

Product Datasheets

You must select a language.

x

265-AN (with carrier)

Product Datasheet

You must select a language.

x

265-AN/CF (carrier free)

Product Datasheet

Carrier Free

What does CF mean?

CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.

What formulation is right for me?

In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.

265-AN

Formulation Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein.
Reconstitution Reconstitute at 10 μg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 6 months from date of receipt, -20 to -70 °C as supplied.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.

265-AN/CF

Formulation Lyophilized from a 0.2 μm filtered solution in PBS.
Reconstitution Reconstitute at 100 μg/mL in sterile PBS.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 6 months from date of receipt, -20 to -70 °C as supplied.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.

Assay Procedure

Materials
(Note: prepare all reagents with RNAse-free deionized water)
  • Recombinant Human Angiogenin (rhAngiogenin) (Catalog # 265-AN)
  • Angiogenin Dilution Buffer: PBS, 0.1% BSA
  • Standard Curve Buffer: 30 mM HEPES, 0.1% BSA, pH 7.0
  • 0.3 M Hepes, 0.3 M NaCl, pH 7.0
  • BSA, 0.1% in deionized water
  • tRNA, Type X (Sigma, Catalog # R9001), 600 units/mL in Standard Curve Buffer
  • RNAse-free water (Ambion cat # AM9920, DEPC treated water)
  • Perchloric Acid (Fisher, Catalog # A469-250)
  • 96 well clear UV-transparent microplate (Corning, Catalog # 3635)
  • UV transparent Spectophotometer cuvette
  • Plate Reader (Model: Spectramax Plus by Molecular Devices) or equivalent
  1. Reconstitute bottled rhAngiogenin to 100 µg/mL with Angiogenin Dilution Buffer.
  2. Dilute the 100 µg/mL rhAngiogenin to 40, 26.7, 17.8, 11.9, 7.9 and 5.26 µg/mL with Standard Curve Buffer. Include two blank controls.
  3. Prepare reagent mix using the following volumes for each one tube tested. Prepare at least one extra tube to accommodate volumetric recovery loss (ie. prepare 9x for this protocol: six dilutions and two blanks per lot of rhAngiogenin tested):
       0.3 M Hepes, 0.3 M NaCl, pH 7.0       1x=20 µL
       0.1% BSA                                              1x=20 µL
       tRNA, 600 units/mL                              1x=20 µL
       RNAse-free deionized water               1x=90 µL
  4. Combine 150 µL of reagent mix and add 50 µL of each rhAngiogenin dilution to the appropriate tubes. As controls, combine 150 µL of reagent mix with 50 µL of Angiogenin dilution buffer. Mix well.
  5. Incubate tubes at 37 °C for two hours.
  6. Dilute perchloric acid to 6% (v/v) in RNAse-free deionized water. Place on ice.
  7. After incubation, add 200 µL cold 6% perchloric acid to each tube. Mix well and incubate on ice for at least 10 minutes.
  8. Centrifuge tubes at 2-8 °C at 13,000 rpm for 20 minutes.
  9. Add 200 µL RNAse-free water to a third set of tubes and place on ice.
  10. Carefully transfer 100 µL of supernatant from each sample to a tube of RNAse-free water prepared in step 9. Mix well.
  11. Load 200 µL from each tube into a UV plate. Load reaction blanks, followed by low to high concentrations of rhAngiogenin.
  12. Fill cuvette with RNAse-free water and place in cuvette port (required for path length correction).
  13. Read the plate at 260 nm in endpoint mode.
  14. Plot a linear curve with the amount of rhAngiogenin (µg per well) on the x-axis, and the adjusted Abs260 on the y-axis:
     Adjusted Abs260 = [Abssample - Absblank] x 6 (dil. factor)
  15. The rhAngiogenin activity is equal to the slope of the plot ( delta Abs260/µg rhAngiogenin).
Per Reaction:
  • rhAngiogenin: 2.00, 1.330, 0.889, 0.593, 0.395, 0.263, 0 µg
  • tRNA: 60 units/mL

Background: Angiogenin

Angiogenin was initially purified from serum-free media conditioned by growth of a human adenocarcinoma cell line HT-29 based on its ability to initiate vascularization in the chicken embryo chorioallantoic membrane. A number of other tumor, as well as normal, cell lines can also secrete Angiogenin. In addition, Angiogenin is present in normal human plasma at levels as high as 60-120 ng/mL. Unlike other angiogenic factors such as FGF, Angiogenin is neither mitogenic nor chemotactic for vascular endothelial cells in vitro. However, Angiogenin can stimulate capillary and umbilical vein endothelial cells to produce diacylglycerol and secrete prostacyclin by phospholipase activation. Angiogenin, absorbed on plastic, can also support endothelial and fibroblast cell adhesion and spreading.

Surprisingly, Angiogenin has been found to be a member of the ribonuclease superfamily with approximately 35% sequence similarity at the amino acid level with pancreatic RNase. Angiogenin exhibits ribonucleolytic activity that is distinctly different than that of pancreatic RNase A. The ribonucleolytic activity of Angiogenin toward most RNase A substrates is much lower than that of RNase A. Nevertheless, the ribonucleolytic activity of Angiogenin is essential to its angiogenic activity since inhibition of the Angiogenin RNase activity will also abolish angiogenesis activity. Similar to several members of the RNase superfamily, Angiogenin is a cytotoxic agent that can abolish cellular protein synthesis. It has been demonstrated that Angiogenin-dependent protein synthesis inhibition can be attributed to the function of Angiogenin as a cytotoxic tRNA-specific RNAase.

A cell-surface Angiogenin binding protein has been purified and characterized. Tryptic peptide mapping and sequence analysis indicate that this binding protein is a member of the actin family.

Entrez Gene IDs
283 (Human)
Alternate Names
ALS9; ANG; Angiogenin; angiogenin, ribonuclease, RNase A family, 5; EC 3.1.27; EC 3.1.27.-; epididymis luminal protein 168; HEL168; MGC22466; MGC71966; Ribonuclease 5; RNase 5; RNASE5RNASE4

Citations for Recombinant Human Angiogenin Protein

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

10 Citations: Showing 1 - 10
Filter your results:

Filter by:

  1. RTCB Complex Regulates Stress-Induced tRNA Cleavage
    Authors: Y Akiyama, Y Takenaka, T Kasahara, T Abe, Y Tomioka, P Ivanov
    International Journal of Molecular Sciences, 2022-10-28;23(21):.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  2. Osteoclasts protect bone blood vessels against senescence through the angiogenin/plexin-B2 axis
    Authors: X Liu, Y Chai, G Liu, W Su, Q Guo, X Lv, P Gao, B Yu, G Ferbeyre, X Cao, M Wan
    Nature Communications, 2021-03-23;12(1):1832.
    Species: Mouse
    Sample Types: In Vivo
    Applications: Bioassay
  3. Plant-derived angiogenin fusion protein's cytoprotective effect on trabecular meshwork damage induced by Benzalkonium chloride in mice
    Authors: JH Jeong, SJ Lee, K Ko, JH Lee, J Lyu, MH Park, J Kang, JC Kim
    PeerJ, 2020-05-22;8(0):e9084.
    Species: Human
    Sample Types: N/A
    Applications: Western Blot
  4. Loss of angiogenin function is related to earlier ALS onset and a paradoxical increase in ALS duration
    Authors: KC Aluri, JP Salisbury, JHM Prehn, JN Agar
    Sci Rep, 2020-02-28;10(1):3715.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In Vivo
  5. Angiogenin and Osteoprotegerin are type II muscle specific myokines protecting pancreatic beta-cells against proinflammatory cytokines
    Authors: S Rutti, R Dusaulcy, JS Hansen, C Howald, ET Dermitzaki, BK Pedersen, M Pinget, P Plomgaard, K Bouzakri
    Sci Rep, 2018-07-03;8(1):10072.
    Species: Human, Rat
    Sample Types: Whole Cells
    Applications: Bioassay
  6. Pleiotropic activity of systemically delivered angiogenin in the SOD1G93Amouse model
    Authors: M Crivello, SL O'Riordan, I Woods, S Cannon, L Halang, KS Coughlan, MC Hogg, SA Lewandowsk, JHM Prehn
    Neuropharmacology, 2018-02-25;133(0):503-511.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In Vivo
  7. Angiogenin-cleaved tRNA halves interact with cytochrome c, protecting cells from apoptosis during osmotic stress.
    Authors: Saikia M, Jobava R, Parisien M, Putnam A, Krokowski D, Gao X, Guan B, Yuan Y, Jankowsky E, Feng Z, Hu G, Pusztai-Carey M, Gorla M, Sepuri N, Pan T, Hatzoglou M
    Mol Cell Biol, 2014-04-21;34(13):2450-63.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Bioassay
  8. Angiogenic sprouting is regulated by endothelial cell expression of Slug.
    Authors: Welch-Reardon K, Ehsan S, Wang K, Wu N, Newman A, Romero-Lopez M, Fong A, George S, Edwards R, Hughes C
    J Cell Sci, 2014-02-19;127(0):2017-28.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  9. The hedgehog system in ovarian follicles of cattle selected for twin ovulations and births: evidence of a link between the IGF and hedgehog systems.
    Authors: Aad, Pauline, Echternkamp, Sherrill, Sypherd, David D, Schreiber, Nicole B, Spicer, Leon J
    Biol Reprod, 2012-10-04;87(4):79.
    Species: Bovine
    Sample Types: Whole Cells
    Applications: Bioassay
  10. ACTIBIND, a T2 RNase, competes with angiogenin and inhibits human melanoma growth, angiogenesis, and metastasis.
    Authors: Schwartz B, Shoseyov O, Melnikova VO, McCarty M, Leslie M, Roiz L, Smirnoff P, Hu GF, Lev D, Bar-Eli M
    Cancer Res., 2007-06-01;67(11):5258-66.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In Vivo

FAQs

No product specific FAQs exist for this product, however you may

View all Proteins and Enzyme FAQs

Reviews for Recombinant Human Angiogenin Protein

There are currently no reviews for this product. Be the first to review Recombinant Human Angiogenin Protein and earn rewards!

Have you used Recombinant Human Angiogenin Protein?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review